Search tips
Search criteria 


Logo of jbcThe Journal of Biological Chemistry
J Biol Chem. 2016 February 19; 291(8): 3821–3836.
Published online 2015 December 22. doi:  10.1074/jbc.M115.680983
PMCID: PMC4759163

Cyclic AMP-elevating Agents Promote Cumulus Cell Survival and Hyaluronan Matrix Stability, Thereby Prolonging the Time of Mouse Oocyte Fertilizability*An external file that holds a picture, illustration, etc.
Object name is sbox.jpg


Cumulus cells sustain the development and fertilization of the mammalian oocyte. These cells are retained around the oocyte by a hyaluronan-rich extracellular matrix synthesized before ovulation, a process called cumulus cell-oocyte complex (COC) expansion. Hyaluronan release and dispersion of the cumulus cells progressively occur after ovulation, paralleling the decline of oocyte fertilization. We show here that, in mice, postovulatory changes of matrix are temporally correlated to cumulus cell death. Cumulus cell apoptosis and matrix disassembly also occurred in ovulated COCs cultured in vitro. COCs expanded in vitro with FSH or EGF underwent the same changes, whereas those expanded with 8-bromo-adenosine-3′,5′-cyclic monophosphate (8-Br-cAMP) maintained integrity for a longer time. It is noteworthy that 8-Br-cAMP treatment was also effective on ovulated COCs cultured in vitro, prolonging the vitality of the cumulus cells and the stability of the matrix from a few hours to >2 days. Stimulation of endogenous adenylate cyclase with forskolin or inhibition of phosphodiesterase with rolipram produced similar effects. The treatment with selective cAMP analogues suggests that the effects of cAMP elevation are exerted through an EPAC-independent, PKA type II-dependent signaling pathway, probably acting at the post-transcriptional level. Finally, overnight culture of ovulated COCs with 8-Br-cAMP significantly counteracted the decrease of fertilization rate, doubling the number of fertilized oocytes compared with control conditions. In conclusion, these studies suggest that cAMP-elevating agents prevent cumulus cell senescence and allow them to continue to exert beneficial effects on oocyte and sperm, thereby extending in vitro the time frame of oocyte fertilizability.

Keywords: apoptosis, cyclic AMP (cAMP), extracellular matrix, fertilization, hyaluronan, cumulus cells


The formation of the antral cavity in the ovarian follicle separates most of the follicle cells from the oocyte with the exception of a small mass of follicle cells, named cumulus cells or cumulus oophorus, which remain closely associated with the oocyte, forming the cumulus cell-oocyte complex (COC).2 These cells play a critical role in the regulation of meiotic resumption and acquisition of developmental competence by the oocyte during the time preceding ovulation (1,5). Reciprocally, the oocyte deeply influences gene expression in these cells by modulating their response to gonadotropins and paracrine factors synthesized by the cells of the follicle wall, namely mural granulosa cells (6). One of the most evident changes controlled by the oocyte in mouse cumulus before ovulation is the expansion process (i.e. the synthesis of an abundant extracellular matrix with unique physical properties) (7). This matrix is highly hydrated and incredibly extensible and viscous due to the elevated concentration of high molecular weight HA probably cross-linked by proteins, such as IαI, PTX3, and TSG6 (8,12). During this process, the connections among cumulus cells and between cumulus cells and oocyte are progressively lost, but the cells remain associated with the oocyte, being embedded in the expanded matrix. This oocyte envelope is essential for successful ovulation and fertilization. The visco-elasticity of the matrix allows the oocyte to wriggle out of the follicle and to be captured by the ciliary epithelium of the oviduct (13, 14). In addition, abnormal cumulus expansion impairs oocyte fertilization (7). In fact, this matrix can be easily crossed by the sperm, and its integral components, as well as soluble factors released by the cumulus cells, are involved in attracting the sperm toward the oocyte and in promoting capacitation and initiating acrosome reaction, processes required for successful fertilization (15, 16). It is well known that oocytes must be fertilized within a narrow window of time from ovulation. After this time, a series of ooplasmic modifications, collectively known as oocyte aging, rapidly occurs in the female gamete, diminishing its fertilizability and embryo developmental potential (17, 18). Delayed fertilization of the ovulated oocytes results in early pregnancy loss and increased offspring morbidity in rodents and appears to increase the risk of abortion in humans (19,21). A reduction in meiotic promoting factor, which regulates the exit from Met II block, occurs in the mouse oocyte as early as 6 h after ovulation. Moreover, disorganization of cortical actin cytoskeleton and displacement and instability of the spindle are clearly apparent after 12 h of staying in the oviduct, accounting for the increased incidence of scattering of chromosomes and cytoplasm fragmentation upon fertilization that is a prelude to embryonic aneuploidy (17, 18). Interestingly, a progressive reduction in cumulus cell mass parallels the aging of the enclosed oocyte, leading almost to oocyte denudation in ~15 h (i.e. about 28 h after an ovulatory dose of human chorionic gonadotropin (hCG)) (22). Metabolic labeling of newly synthesized HA by COCs induced to expand in vitro with FSH allowed the determination that disassembly of the viscoelastic matrix begins 3–4 h after the completion of expansion and continues thereafter, promoting the shedding of cumulus cells (23, 24). The HA was released from the matrix into the medium without any significant variation in size (23), suggesting that the disassembly of the matrix is not dependent on cleavage of this polymer but rather on degradation of proteins involved in its organization. Degeneration of cumulus cells has been described in mouse postovulatory COCs (25) and apoptosis signature has been revealed in rat COCs after a prolonged staying in the oviduct (26). However, a precise estimate of the functional life of cumulus cells and its correlation with cumulus matrix degradation and oocyte aging is missing. In view of the pressing need to improve the conditions for promoting and preserving the quality of the oocytes during their culture and handling in assisted reproduction programs, we performed a systematic study on temporal patterns of cumulus cell apoptosis and dispersion in ovulated COC and in COC expanded in vitro in order to identify factors regulating these processes and to determine the impact they might have on the fertile life of the oocyte.

Experimental Procedures


Pregnant mares' serum gonadotropin (PMSG) and hCG were purchased from Intervet (Boxmeer, The Netherlands). Highly purified rat FSH I-8 was kindly provided by the NIDDK and the National Hormone and Pituitary Program, National Institutes of Health (Bethesda, MD). Epidermal growth factor (EGF), cycloheximide, UO126, and Streptomyces hyaluronidase were purchased from Calbiochem. Transforming growth factor β (TGFβ) was obtained from R&D System. Minimal essential medium, fetal calf serum (FCS), gentamycin, and HEPES buffer were obtained from Gibco, Invitrogen. Mineral oil, l-glutamine, sodium pyruvate, 8-bromo-adenosine-3′,5′-cyclic monophosphate (8-Br-cAMP), dbcAMP, 8-AHA-cAMP, 6-Mb-cAMP, forskolin, H89, LY294002, and wortmannin were from Sigma. 8-pCPT-2′-O-Me-cAMP was from Biolog. Sephadex G50 was from Amersham Biosciences. [3H]Glucosamine was obtained from PerkinElmer Life Sciences. The in situ cell death detection kit was purchased from Roche Applied Science.


Immature 21–22-day-old female Swiss CD1 mice were used for all experiments. Animals were primed by intraperitoneal injection of PMSG (5 IU) to promote the formation of multiple antral follicles and, 44–48 h later, received an intraperitoneal injection of hCG (5 IU) to induce ovulation. All experiments were approved by the institutional animal care and use committee and carried out according to Italian and European regulations (D.L.vo 116/92; C.E. 609/86).

Induction and Culture of in Vitro Expanded COCs

Ovaries were dissected from mice injected 44–48 h earlier with PMSG and transferred to minimal essential medium containing 25 mm Hepes, 50 μg/ml gentamycin, 0.3 mm sodium pyruvate, and 1 mg/ml BSA. COCs were isolated under the microscope by puncturing the larger follicles with a needle. For each culture, 10 compact COCs were collected by a glass micropipette and transferred to a 20-μl drop of culture medium covered with dimethylpolysiloxane to prevent evaporation. The basal culture medium was minimal essential medium supplemented with 5% FCS, 3 mm glutamine, 0.3 mm sodium pyruvate, and 50 ng/ml gentamycin. Expansion was induced by adding to the medium either 20 ng/ml FSH, 1 ng/ml EGF, or 1 mm 8-Br-cAMP, and the cells were cultured at 37 °C, 5% CO2. Full expansion was achieved at 15 h of culture, and disassembly of the expanded matrix and cumulus cell apoptosis were investigated thereafter at the times indicated under “Results.” When the effect of 8-Br-cAMP on FSH- or EGF-expanded COCs was studied, 2 μl of medium was removed from the 20-μl drop at 15 h of culture and replaced with 2 μl of 10 mm 8-Br-cAMP to reach a final concentration of 1 mm. The same procedure was used to study the effect of H89, LY294002, wortmannin, and UO126 on 8-Br-cAMP action. In this case, the inhibitors were added 1 h before (14 h of culture with FSH or EGF) 8-Br-cAMP. Cultures of isolated cumulus cells were performed by mechanical dissociation of 10 COCs in a 20-μl culture medium drop and removal of the oocytes, as described (27). Expansion was induced with 100 ng/ml FSH and 5 ng/ml TGFβ.

Isolation and Culture of Ovulated COCs

In studies of apoptosis in vivo, animals were sacrificed at 13 h (time of ovulation), 20 h, or 24 h after hCG injection. Oviducts were dissected and transferred to HEPES-buffered medium (see above). Ampullae were opened with a needle, and the ovulated COCs were immediately processed. To study apoptosis in ovulated COCs cultured in vitro, COCs obtained from three oviducts of three different mice were cultured in 500 μl of minimal essential medium supplemented with 1 mg/ml BSA, 3 mm glutamine, 0.3 mm sodium pyruvate, 50 ng/ml gentamycin and treated with 1 mm 8-Br-cAMP or other compounds reported under “Results” at 37 °C, 5% CO2 for the time indicated. When the effect of H89, LY294002, wortmannin, and UO126 on 8-Br-cAMP action was studied, the inhibitors were added at the beginning of culture, and 8-Br-cAMP was added 1 h later. The dissociation of the matrix was assessed by morphological evaluation and expressed in arbitrary units from 0 (intact COC) to 4 (denuded oocyte).

In Vitro Fertilization

COCs were collected at 13 h after hCG and cultured for 14 h in 500 μl of basal medium containing 5% FCS with or without 1 mm 8-Br-cAMP. To normalize biological variability, the COCs collected from the oviducts of each animal were equally distributed in the two experimental culture conditions. Oocytes denuded of cumulus cells were obtained from COCs isolated at 13 h after hCG by digesting the matrix with 30 units/ml testicular hyaluronidase for 5 min at room temperature. After dispersion of cumulus cells, denuded oocytes were collected and cultured in the same conditions and for the same time as COCs.

Cumulus cell oocyte complexes and denuded oocytes either freshly isolated (0 h of culture) or cultured in vitro for 14 h were transferred to a 100-μl drop of Whitten's medium supplemented with 15 mg/ml BSA. Spermatozoa were obtained from the epididymis of CD1-proven breeders and were capacitated (2 h) in the same medium used for fertilization. Subsequently, 10 μl of a sperm suspension containing 5–10 × 106 spermatozoa/ml was added to oocyte cultures. After 6 h, the oocytes were observed via the interference-contrast microscope to determine the fraction undergoing fragmentation and the fraction normally fertilized, by the identification of the two pronuclei. The development of the embryo at the two-cell stage was assessed at 24 h after insemination.

Qualitative and Quantitative Analysis of Apoptosis

COCs were fixed for 30 min at room temperature with 4% paraformaldehyde in PBS (pH 7.4). After washing with PBS containing 1 mg/ml BSA, COCs were processed for TUNEL staining. Cells were permeabilized for 2 min in 0.1% Triton X-100 in PBS. After a wash with PBS containing 1 mg/ml BSA, COCs were incubated for 60 min at 37 °C with TUNEL reaction mixture, according to the manufacturer's instructions. A negative control was included by incubating COCs in TUNEL reaction mix without TdT. To visualize chromatin, COCs were counterstained with 5 μg/ml Hoechst 33258 for 5 min and washed extensively with PBS containing 1 mg/ml BSA. COCs were individually transferred in a small volume on a slide and gently pressed under a coverslip until cumulus cells, dispersed in the tridimensional structure of the matrix, lay on the same focal plane. Cells were examined by an Olympus Axioplan 2 microscope in fluorescent mode. Cells showing a homogeneous and moderate chromatin staining by Hoechst 33258 throughout the entire nucleus resulted in negative TUNEL staining and therefore were considered healthy cells. On the contrary, cells with nuclei containing chromatin deeply stained with Hoechst 33258, either merged into masses aligned with the nuclear membrane, shrunken into a single mass, or fragmented into multiple masses that occurred in clusters immediately adjacent to one another, resulted in TUNEL-positive staining and were therefore defined as apoptotic cells. Pilot experiments showed that quantitative evaluation of apoptosis performed by nuclear morphology matched that made by TUNEL staining. Therefore, in the following experiments, COCs were stained with Hoechst 33258, and cells with healthy and apoptotic features were counted in six random fields for each COC through a ×400 magnification in fluorescent mode. The percentage of apoptotic cells was calculated for each COC. Between 7 and 10 COCs for each sample were analyzed in each experiment.

Quantitative Analysis of HA Matrix Disassembly

In order to evaluate the distribution of HA between cell matrix and medium compartments during matrix disassembly, 10 COCs were cultured in a 20-μl drop of medium in the presence of FSH, EGF, or 8-Br-cAMP (see above) and with [3H]glucosamine (100 μCi/ml). Cultures were analyzed at 15 h, when full expansion is achieved, and at later times, as indicated under “Results.” At the end of culture, medium and cell matrix were processed separately, and the percentage of HA in the two compartments was assessed as described previously (28). Briefly, the incubation medium was aspirated, and the medium and matrix fractions were separately treated with 20 μl of a papain solution (750 mIU final activity) for 1 h at 65 °C. The extraction was completed by adding 1 volume of 8 m guanidine HCl containing 4% (w/v) Triton X-100. Each extract was heated at 100 °C for 3 min to inactivate the papain and diluted to 500 μl by adding 0.1 m Tris, 0.1 m sodium acetate, pH 7.3, followed by elution on a column of Sephadex G50 (2-ml bed volume) equilibrated with 0.1 m Tris, 0.1 m sodium acetate, and 0.5% Triton X-100, pH 7.3. The excluded volume, containing the labeled macromolecules, was recovered and counted. Each sample was then digested with 1 IU of Streptomyces hyaluronidase (Calbiochem) for 2 h at 37 °C and then eluted on a column of Sephadex G-50 (8-ml bed volume). The excluded and the included fractions were counted to determine the HA proportion of the total radiolabeled molecules.

To compare the rate and time course of HA synthesis in different conditions, the mass of HA synthesized was determined (in hexosamine equivalents) at different times of culture from 3 to 40 h, as described previously (8). Briefly, COCs were stimulated in the presence of [35S]sulfate (~60 μCi/ml) and [3H]glucosamine (100 μCi/ml), and the specific activity of the UDP-N-acetylhexosamine pools was calculated from the ratio of 3H to 35S in the proteoglycan 4S disaccharides.

Morphological Analysis of Matrix Elasticity

COCs were transferred in a 20-μl drop of medium. Movies were captured during aspiration of the medium (i.e. under the pressure exerted by the increase of superficial tension), and during the release back of the medium (i.e. the decrease of the applied force). A Nikon Eclipse Ti microscope using a ×10, numerical aperture 0.25 Nikon PLAN objective and NIS Elements imaging software were used.

Statistical Analysis

The data represent the mean ± S.E. of at least three independent experiments. Statistical significance of the difference between two treatments was analyzed by Student's t test, whereas one-way analysis of variance with the addition of Turkey's test was used for multiple comparisons. A p value of <0.05 was considered significant.


Cumulus Cell Apoptosis Parallels Matrix Disassembly in Ovulated COCs

Following hCG injection into PMSG-primed mice, compact COCs undergo volumetric expansion for the deposition of an abundant HA-enriched extracellular matrix. At 13 h after hCG, fully expanded COCs are released from the ovarian follicles and captured by the oviducts. A progressive reduction in cumulus cell mass occurs in the oviduct during the following time leading almost to oocyte denudation in ~11–15 h (24–28 h after hCG) (Fig. 1A). Nuclear morphology of cumulus cells was examined at different times during the postovulatory period by Hoechst 33258 staining (Fig. 1B). At ovulation (13 h after hCG), almost all cumulus cells showed intact nuclei with low and quite homogeneous chromatin staining, but 7 and 11 h later (at 20 and 24 h after hCG, respectively), a large number of cells with highly condensed chromatin, either shrunken into a single mass or fragmented into multiple masses, was observed. TUNEL staining clearly revealed that cells with the above mentioned morphological features contained fragmented DNA (Fig. 1B). Then, for a quantitative evaluation of apoptosis, chromatin staining was performed, and the number of apoptotic cells was counted and expressed as a percentage of the total number of cells/COC (Fig. 1C). Cumulus cell-oocyte complexes isolated from the ovary 4 h before ovulation (9 h after hCG) showed almost no sign of apoptosis (0.9 ± 0.05%), and those freshly ovulated (13 h after hCG) had very few apoptotic cells (2.3 ± 0.5%). The percentage of apoptotic cells abruptly increased thereafter, ~8- and 15-fold at 4 and 7 h after ovulation, respectively (17 and 20 h after hCG), reaching a value of 35.8 ± 3%. The apoptotic rate did not apparently increase further during the following 4 h (i.e. at 24 h after hCG). However, at this later time, the number of cells surrounding the oocyte was extremely reduced, and much scattered cellular debris containing a variable amount of condensed chromatin was present (Fig. 1B). For this reason, 20 h after hCG was the time chosen to investigate the apoptotic process in the following experiments.

Cumulus cells undergo apoptosis after ovulation. Mice were injected with PMSG to promote the formation of antral follicles and, after 48 h, were injected with hCG to induce ovulation. COCs were isolated at different times after the administration of hCG. ...

To determine whether cumulus cell apoptosis was induced by the oviductal environment, COCs were collected at 13 h after hCG and cultured in vitro. The number of apoptotic cells/COC was then evaluated after 7 h of culture and compared with that observed in COCs retrieved from the oviducts 7 h after ovulation (i.e. at 20 h after hCG). The results showed that the percentage of apoptotic cells significantly increased during in vitro culture, reaching the same value observed in COCs maintained for the same time in the oviduct (Fig. 1D). Therefore, it seems that cumulus cell death is not due to detrimental effects by the oviduct.

A series of studies highlighted the essential role of endocrine and paracrine factors in sustaining mural granulosa cell survival in the ovarian follicles (29). It has been reported that mural granulosa cells cultured in vitro undergo apoptosis unless serum or growth factors, including EGF, basic FGF, insulin-like growth factor, or gonadotropins were added to the cultures. To investigate whether the onset of cumulus cell apoptosis after ovulation could be due to the deprivation of follicle survival factors, ovulated COCs were cultured for 7 h with the factors mentioned above (Fig. 1C). As shown in Fig. 1D, neither serum nor any of the growth factors tested were effective in preventing spontaneous onset of apoptosis by ovulated cumulus cells. Luteinizing hormone also failed in suppressing cumulus cell death, and FSH slightly inhibited the process, although the difference from control (BSA) did not reach statistical significance (p = 0.059).

According to previous findings (24), COC matrix became loose during culture in all conditions mentioned above, and apoptotic and healthy cells were progressively released into the medium. The healthy cells individually settled on the dish, and those that formed aggregates or adhered to the plastic, in the absence and in the presence of serum, respectively, remained viable for several days (data not shown).

Cumulus Cell Apoptosis and Matrix Disassembly in COC Matured in Vitro

To determine whether cumulus cell apoptosis also occurs in COC matured in vitro, compact COCs were isolated from PMSG-primed follicles and cultured in the presence of 5% FCS with either FSH or EGF or the membrane-permeable cAMP analogue 8-Br-cAMP. These factors were shown previously to stimulate in vitro COC expansion, which marks the final maturation of the cumulus. Metabolic labeling showed that, whatever the factor used, the amount of newly synthesized HA increased up to 15 h of culture and remained constant thereafter (Fig. 2A). Thus, the time course of apoptosis was evaluated in each condition starting from 15 h of culture (Fig. 2B), when HA synthesis ceased and full expansion was achieved. The apoptotic rate in COCs cultured in the presence of FSH was low at the end of the expansion process, ranging between 3 and 4%, and progressively increased after 18 h of culture, reaching a value of ~20% at 24 h (9 h after completion of expansion), mimicking the in vivo condition. Shedding of apoptotic and healthy cumulus cells from the complex to the culture medium occurred during the culture time leading to oocyte denudation (Fig. 2D). In agreement, metabolic labeling of HA synthesized during in vitro expansion showed that 80–90% of HA was organized in the matrix at 15 h and that a progressive HA release into the medium occurred afterward in parallel to the increase of the apoptotic rate (Fig. 2C). Interestingly, the number of apoptotic cells in EGF-stimulated COCs was significantly higher than in FSH-treated COCs at the completion of expansion (Fig. 2B) (p < 0.001). Nonetheless, the apoptotic rate abruptly increased between 18 and 24 h of culture, coincident with HA release and cumulus dispersion, similar to what was observed for the FSH-treated COCs (Fig. 2, B–D). It is noteworthy that COCs cultured in the presence of 8-Br-cAMP (or dbcAMP; data not shown), as with FSH, showed a low number of apoptotic cells at 15 h, but, conversely to what was observed with the gonadotropin, the apoptotic rate did not increase at 24 h. Even at 40 h of culture (25 h after completion of expansion), the apoptotic rate did not exceed 10%. In addition, whereas in FSH-stimulated COCs, the elastic matrix, formed within the first 15 h of culture (supplemental Movie S1), was completely disassembled at 40 h and the cumulus cells dissociated from the oocyte (supplemental Movie S2), COCs cultured for 40 h with 8-Br-cAMP had a large number of cells still surrounding the oocytes (Fig. 2D) and showed the same ability as at 15 h of culture to stretch under compression and to resume their shape after force release (supplemental Movies S3 and S4), suggesting that the structure and the muco-elastic properties of the matrix were preserved by this cAMP analogue. In agreement, no significant amount of HA was shed into the medium between 15 and 24 h of culture, and only 25% HA was released during the following 16 h (Fig. 2C).

Temporal pattern of apoptosis and matrix disassembly in COC matured in vitro. Compact COCs were collected from PMSG-primed mice and induced to expand in vitro with 20 ng/ml FSH, 1 ng/ml EGF, or 1 mm 8-Br-cAMP in the presence of 5% FCS. A, time course ...

Elevation of cAMP Levels Prevents Apoptosis and Matrix Disassembly in COCs Matured in Vitro and in Vivo

The observation that apoptosis and matrix disassembly were abrogated in the presence of 8-Br-cAMP prompted us to assess whether COCs expanded in response to FSH or EGF could be rescued by 8-Br-cAMP. Compact COCs were cultured in the presence of FSH or EGF for 15 h. At that time (i.e. before the beginning of the degradation process), 8-Br-cAMP was added to the culture medium. The results showed that the cAMP analogue was able to prevent apoptosis in FSH-stimulated COCs and significantly delay the dissociation of the matrix up to 40 h of culture (Fig. 3, A and B). Similar results were obtained when COCs were expanded with EGF (Fig. 3, C and D). Indeed, although EGF-stimulated COCs showed an elevated apoptotic rate at 15 h, the addition of 8-Br-cAMP prevented the progression of this process as well.

Onset of spontaneous apoptosis and matrix disassembly in FSH- and EGF-stimulated COCs are counteracted by 8-Br-cAMP at an early pre-apoptotic stage. Compact COCs were cultured with 20 ng/ml FSH (A and B) or 1 ng/ml EGF (C and D) in the presence of 5% ...

Then we investigated whether cell viability and matrix stability of in vivo matured COC could be prolonged in culture. For this purpose, COCs were collected from the oviducts soon after ovulation (13 h after hCG) and cultured with or without 8-Br-cAMP or dbcAMP for 7 h. The results show that both cAMP analogues reduced by 70–80% the apoptotic rate (Fig. 4A). The same result was obtained by culturing COCs with forskolin, which, activating adenylate cyclase, increases the endogenous intracellular cAMP level. In addition, rolipram, a specific inhibitor of phosphodiesterase 4 that is mainly responsible for cAMP degradation in cumulus cells (30), attenuated apoptosis in a dose-dependent manner (Fig. 4B). Notably, the treatment with 8-Br-cAMP maintained the integrity of ovulated COCs beyond 48 h after hCG injection (i.e. for >1.5 days of culture) (Fig. 4C).

Elevation of cAMP level prolongs in vitro cell viability and integrity of ovulated COCs. Ovulated COCs were collected at 13 h after hCG, and the apoptotic rate was evaluated at 7 h of culture (total 20 h after hCG) in the absence (basal medium (BM)) or ...

Previous studies have shown that oocyte secreted factors play critical roles in the regulation of cumulus cell functions before ovulation, including the promotion of cumulus cell survival (31) and cumulus matrix deposition (27, 32). We then assessed whether the oocyte might influence the grade and the time course of cumulus cell apoptosis and matrix remodeling after ovulation. To this purpose, ovulated COCs were deprived of oocytes (oocytectomized complexes) and cultured in vitro. Analysis at 7 h of culture showed no difference in the apoptotic rate between cumuli cultured with and without the enclosed oocyte (Fig. 5A) (p = 0.097). Similar results were obtained with isolated cumulus cells expanded in vitro. Compact COCs were mechanically dissociated, and oocyte was discarded. Isolated cumulus cells were then stimulated with FSH in the presence of TGFβ, a growth factor able to substitute for the oocyte in promoting expansion (33). Apoptotic rate as well as the temporal pattern of HA release from the expanded matrix were similar in cumulus cells cultured with (intact COC) and without oocytes (CC) (Fig. 5, B and C). Notably, 8-Br-cAMP inhibited cumulus cell apoptosis and HA release also in the absence of oocytes, indicating that the beneficial effect of 8-Br-cAMP is direct on cumulus cells and not mediated by the germ cell (Fig. 5, B and C).

The oocyte does not influence the pattern of apoptosis and matrix disassembly in COCs after ovulation. A, ovulated COCs were collected at 13 h after hCG, and the enclosed oocyte was punctured with a needle under the microscope. The resulting oocytectomized ...

The Effect of 8-Br-cAMP Is Exerted through PKA Activation

Mechanisms for the response to cAMP can involve either the protein kinase A (PKA), also known as cAMP-dependent protein kinase, or EPAC (exchange protein directly activated by cAMP), which is a guanidine nucleotide exchange factor for the small GTPases Rap1 and Rap2 (34). To discriminate between the two possibilities, we used cAMP analogues with higher affinity for one or the other signaling molecule. We found that the cAMP analogue 8-pCPT-2′-O-Me-cAMP, capable of selective EPAC activation (35), was unable to maintain the integrity of COCs at any of the concentrations tested up to 1 mm (Fig. 6).

Effects of a selective EPAC activator cAMP analogue on dissociation of ovulated COCs cultured in vitro. Shown are representative micrographs of COCs collected at 13 h after hCG and cultured for 7 h in the presence of different concentrations of 8-pCPT-2′-O-Me-cAMP, ...

Two major isozymes of PKA, type I and type II, were found, which differ in the regulatory subunit (R). In each subunit R, there are two cAMP binding sites, site 1 and site 2, and when both sites are occupied by cAMP, a drastic reduction in the affinity of R to the catalytic subunit occurs, leading to the dissociation of active catalytic subunits. The two types of holoenzymes can be selectively activated by the synergistic action of pairs of specific cAMP analogues that at low concentrations individually bind to site 1 and site 2 on RI or RII. Therefore, to confirm a role of PKA and to determine which PKA isozyme was responsible for the observed cAMP-dependent effects, we used the following three analogues: 8-Br-cAMP, binding preferentially to site 1 of RII; 8-AHA-cAMP, binding preferentially to site 1 of RI; and the analogous 6-Mb-cAMP, binding to site 2 in both RI and RII, and, for this reason, able to selectively activate PKA I or PKA II, depending on the analogue with which it is combined (36). Ovulated COCs were cultured in control medium or in a medium containing increasing concentrations of each of the three analogues, and apoptosis was analyzed at 7 h together with cumulus dissociation. As shown in Table 1, no inhibition or only a mild inhibition of apoptosis was obtained with 6-Mb-cAMP and 8-AHA-cAMP at any of the concentrations tested and with 8-Br-cAMP at a concentration of 50 μm. However, when 6-Mb-cAMP was combined with 50 μm 8-Br-cAMP (i.e. the pair of analogues putatively capable of activating PKA II), apoptosis was completely inhibited, whereas no effect was observed when 6-Mb-cAMP was administered in association with 8-AHA-cAMP (i.e. the couple that activates PKA I) (Table 1). As expected, the pair 8-AHA-cAMP and 8-Br-cAMP, activating R subunits of different PKA isotypes, had no effect. These results suggest that stimulation of the PKA II underlies the cAMP-promoted inhibition of cumulus cell apoptosis. Interestingly, 6-Mb-cAMP and 8-AHA-cAMP alone did not show any effect on cumulus dissociation, and, furthermore, inhibition by 8-Br-cAMP required a greater dose. In any case, only the combination of cAMP analogues activating PKA II efficiently inhibited cumulus dispersion, as found for apoptosis.

Effects of cAMP analogues on apoptosis and matrix dissociation in ovulated COCs cultured in vitro

It was demonstrated previously that cAMP elevation in follicle cells activates the PI3K/Akt and MAPK signaling pathways through dependent and independent PKA mechanisms (37,39). Thus, involvement of these kinases in 8-Br-cAMP-induced cumulus cell survival was analyzed in ovulated COCs cultured in vitro for 7 h by using selective inhibitors (Fig. 7A). Consistent with the results reported above, H89, an inhibitor of PKA activity, completely reversed the effect of 8-Br-cAMP. Two chemically different inhibitors of PI3K, LY294002 and wortmannin, produced an acceleration of apoptosis but only partially counteracted the action of 8-Br-cAMP. Treatment of the cells with UO126, a dual inhibitor of MEK1 and MEK2, which phosphorylate and activate MAPKs, had no effect. These results suggest that PKA is the dominant kinase for long term cumulus cell survival and that it might act through multiple pathways.

Signaling pathways involved in the protective action of cAMP on apoptosis and matrix disassembly. A, effect of PKA inhibitor H89, PI3K inhibitors LY294002 and wortmannin, and MAPKK inhibitor UO126 on apoptosis. Ovulated COCs were preincubated for 1 h ...

Conversely, the effect of 8-Br-cAMP on matrix stability was not apparently altered by H89 or by the other inhibitors in cultured ovulated COCs (data not shown). To study this phenomenon in more detail, we performed metabolic labeling of HA during in vitro FSH-induced COC expansion. At 15 h of culture, inhibitors alone or in association with 8-Br-cAMP were added to the culture medium, and HA release from the matrix was analyzed 9 h later (24 h of total culture) (Fig. 7B). Consistent with the morphological observation, the HA retention in the matrix promoted by 8-Br-cAMP was not inhibited by either H89, LY294002, or UO126. Interestingly, treatment with H89 alone inhibited HA release as efficiently as 8-Br-cAMP. These results may reflect the ability of H89 to inhibit, in addition to PKA, also kinases that can be inhibited downstream from the PKA signaling pathway, a condition that would mimic the action of PKA (40).

8-Br-cAMP Action Does Not Require Protein Synthesis

The apoptotic pathway is regulated by the synthesis of pro- and anti-apoptotic proteins as well as by post-transcriptional modification of regulatory components and executors as caspases. We found that in vitro treatment of ovulated COCs for 7 h with cycloheximide, which blocks protein synthesis, enhanced apoptosis in a dose-dependent manner, inducing 80–90% cell death at the highest doses tested (Fig. 8). It is noteworthy that the 8-Br-cAMP anti-apoptotic action was highly resistant to cycloheximide, with the apoptotic rate not exceeding 20% even at the highest concentrations of the drug. Next, we examined the possibility that 8-Br-cAMP might produce a rapid and reverse modification of apoptotic regulators rather than stimulate new protein synthesis, which would occur over several hours. The time of action of 8-Br-cAMP was then assessed. First, to determine the time course of apoptosis in the absence of 8-Br-cAMP, COCs were cultured in basal conditions, and apoptosis was evaluated at different times. Results reported in Fig. 9A show that apoptosis rapidly increased between 3 and 5 h of culture, reaching the maximum value at 7 h. Conversely, when 8-Br-cAMP was added to the medium at 3 or 5 h of culture, no further increase of apoptosis was found at 7 h. These observations indicated that 8-Br-cAMP was able not only to inhibit the onset of apoptosis but also to promptly block this process when it was ongoing. Then we investigated whether the 8-Br-cAMP effect could be reversed. 8-Br-cAMP was added from the beginning of the culture and washed out at different times. We found that the removal of 8-Br-cAMP at any time between 2 and 24 h of culture allowed the cells to resume the death program (Fig. 9B).

Prevention of spontaneous apoptosis by 8-Br-cAMP is protein synthesis-independent. Ovulated COCs were preincubated for 1 h with different concentrations of cycloheximide, an inhibitor of protein synthesis, and cultured for 7 h in the presence of the inhibitor ...
The cAMP agonist 8-Br-cAMP exerts a rapid and reversible action on cumulus cell apoptosis. A, ovulated COCs were cultured in vitro with 1 mg/ml BSA (basal medium (BM)), and apoptosis was evaluated at 0, 3, 5, and 7 h of culture (solid bars). In another ...

Interestingly, dissociation of ovulated COCs was inhibited by cycloheximide, independent of the presence or the absence of 8-Br-cAMP (Fig. 8). In addition, dispersion of the cumulus was not inhibited when treatment with 8-Br-cAMP was delayed for 3 h (data not shown). These results suggest that synthesis of new proteins is required for matrix remodeling and that cAMP elevation probably prevents changes that irreversibly commit their expression.

Effect of Maintenance of Cumulus Integrity on Oocyte Fertilization

In mammals, the developmental capacity of the oocyte is maintained only for a narrow window of time both in vivo and in vitro. In mice, within 12 h of ovulation, several molecular changes take place in the oocytes, leading to decreased fertilization rate and increased cytoplasmic fragmentation (i.e. default activation pathway) upon insemination (17). Because dispersion of the cumulus parallels the aging of the enclosed oocyte, we wondered whether the maintenance of cumulus integrity could prolong the fertilizability of the oocytes. To explore this question, the in vitro fertilization rate of ovulated COCs cultured for 14 h with and without 8-Br-cAMP was compared with that of COCs inseminated soon after ovulation (time 0 h, control). As shown in Table 2, an increase in oocyte fragmentation and decrease in two-pronucleus formation occurred in both experimental groups. However, the majority of oocytes subjected to insemination after culture without 8-Br-cAMP underwent fragmentation, and the rate of fertilization and two-cell embryo development dropped to about 30 and 25% of the control, respectively. Conversely, when COCs were cultured in the presence of 8-Br-cAMP, the proportion of normally fertilized oocytes as well as two-cell embryo formation was improved, reaching about 70 and 50% of control, respectively. The possibility that 8-Br-cAMP exerted a direct effect on oocytes is unlikely because this cyclic nucleotide did not ameliorate the fertilization rate of denuded oocytes cultured in vitro.

Comparison of fertilization and development of cumulus-enclosed and denuded oocytes cultured for 14 h with and without 8-Br-cAMP


Data reported in this paper show that cumulus cell apoptosis dramatically increases in the oviduct a few hours after ovulation, paralleling matrix remodeling. Both processes were inhibited in vitro by the treatment with either cAMP analogues or by elevating endogenous intracellular cAMP with adenylate cyclase activator forskolin or phosphodiesterase inhibitor rolipram. Notably, the maintenance of COC integrity by cAMP prolonged the fertile life span of ovulated oocytes. These findings provide the first evidence that modulation of cAMP in cumulus cells dictate the time of their survival and consequently the time frame of oocyte fertilization.

Several lines of evidence indicate that, in addition to triggering luteinization of granulosa cells, LH promotes granulosa cell survival during the time preceding ovulation. The observation that cAMP analogues, such as LH, prevent the spontaneous onset of granulosa cell apoptosis in cultured preovulatory follicles suggests that this hormone exerts its protective role mainly via a cAMP-dependent signaling pathway (29). Data reported in this paper suggest that a cAMP-dependent protective mechanism also operates in cumulus cells during the periovulatory follicles. FSH and EGF are able to induce, in concert with oocyte factors, in vitro cumulus expansion, which signals the final differentiation of cumulus cells. These compounds elicit different membrane transduction signals, tyrosine kinase-dependent for EGF and cAMP-dependent for FSH, which probably both converge in activation of MAPKs for stimulating such a process (41, 42). In addition, the stimulation of cumulus cells with either FSH and EGF during in vitro oocyte maturation enhances oocyte developmental competence, as evidenced by the increased rate of embryo and fetal development (43,47). The molecular mechanisms underlying the beneficial effect of these two compounds on oocyte began to be elucidated. It has been recently shown that EGF and EGF-like growth factors are able to generate signals by cumulus cells that control in oocytes the translation of mRNAs relevant for meiotic progression and development (5). We now show that FSH sustains cumulus cell survival. In fact, COCs treated in vitro with EGF show a significantly higher incidence of apoptotic cumulus cells than COCs expanded in vivo, whereas cAMP analogues as well as FSH mimicked the in vivo condition sustaining the survival of cumulus cells throughout the process of cumulus maturation. It should be pointed out that FSH was required to sustain cumulus cell survival although serum was present, a condition that is routinely used for in vitro maturation of mammalian COCs, including human COCs. These results strongly support the benefit of combining EGF and FSH during COC maturation. It is likely that FSH exerts an important role in vivo, as in vitro, in protecting cumulus cells during spontaneous cycles. In fact, a simultaneous surge of circulating FSH is associated with that of LH before ovulation, and cumulus cells, conversely to granulosa cells, almost exclusively express FSH receptors. It is noteworthy that the apoptotic rate of cumulus cells in humans has been associated with poor embryo implantation and pregnancy outcome and proposed as a negative marker for selecting oocytes (48).

By the time of ovulation, matrix deposition ceases, and COCs are transferred to the oviduct, where, shortly after, cumulus matrix disorganization occurs (24). We show here that this matrix changes are associated with progressive cumulus cell death. Seven hours after ovulation, about 30% of the cells showed advanced signs of degeneration, and extracellular matrix had lost most of its elasticity. These events seem to depend on an intrinsic program activated at the final stage of cumulus cell differentiation rather than by adverse oviductal environment. This conclusion is supported by the evidence that freshly ovulated COCs cultured in vitro undergo apoptosis and matrix disassembly with the same temporal course and at the same rate as COCs maintained in the oviduct. In addition, COCs stimulated in vitro with FSH undergo the same changes after completion of expansion, albeit at a lower rate. In this culture condition, almost half of the HA accumulated at the end of cumulus expansion was released from the matrix to the medium during the following 9 h of culture, and about 20% of cells showed apoptotic features.

A decrease of the intracellular cAMP level appears to be functional in the execution of this program. This hypothesis is supported by the evidence that, when 8-Br-cAMP was added to FSH-expanded COCs, no significant HA release or apoptosis occurred within the following 9 h of culture, and most of the cells were still healthy and associated with the oocyte by an elastic matrix even at 24 h after expansion completion. A similar effect was obtained by culturing ovulated COCs in the presence of forskolin, but not in the presence of FSH, indicating that, although ovulated cumulus cells have adequate adenylate cyclase machinery, the hormone failed to activate it. This can be explained by a decreased responsiveness of expanded cumulus cells to this hormone. In fact, it is well known that stimulation of follicle cells with an ovulatory dose of gonadotropins leads to adenylate cyclase desensitization for several hours to further hormone stimulus. In agreement, we have shown previously that FSH stimulates maximum cAMP production by COCs within 2 h of culture, whereas a progressive decline occurs afterward toward the basal level, although FSH was continuously present (49). Finally, a comparative study of gene expression profiles at different stages of cumulus maturation has shown that expression of FSH receptor is down-regulated in COCs after ovulation (50).

The intracellular pathway by which elevation of cAMP prevents matrix disassembly and apoptosis in the cumulus was investigated by site-selective affinity cAMP analogues (35, 36). The ineffectiveness of 8-pCPT-2′-O-Me-cAMP, which selectively binds and activates EPAC, suggests that this intracellular pathway is not involved in controlling cumulus integrity. Only a paired combination of cAMP analogues that synergistically activate the type II PKA was able to recapitulate the effect of the adenylate cyclase activator forskolin, whereas selective PKA I agonists had no effect. This result is in agreement with previous findings suggesting a compartmentalization of the PKA isozymes in the COC with type I PKA being expressed in the oocyte and type II PKA being present in the cumulus cells (51). Type II regulatory subunits show high affinity for several anchoring proteins (AKAPs), which determine different enzyme intracellular localization and action specificity (52). Interestingly, apoptosis and matrix disassembly showed different sensitivity to intracellular cAMP level, because the 8-Br-cAMP minimum effective dose was lower for the former than for the latter, suggesting that these processes are probably controlled by differently sequestered PKA II.

The relevance of PKA activity in preventing cumulus cell apoptosis was confirmed by the ability of the inhibitor H89 to completely reverse the protective effect of 8-Br-cAMP. It has been reported previously that cAMP/PKA can affect the PI3K/AKT and MAPK signaling pathways (37,39), which promote cell survival under several proapoptotic stimuli. However, the failure of the inhibitor of MEK1/MEK2-dependent MAPKs UO126 to influence the apoptosis both in the absence and in the presence of 8-Br-cAMP makes the participation of ERK1 and -2 in the control of this process unlikely. Noteworthy, inhibition of PI3K with both LY294002 and wortmannin accelerated the apoptosis of cumulus cells in control conditions but only partially inhibited the protective action of 8-Br-cAMP, suggesting that although the PIK3 activity is important for cumulus cell survival, PKA acts through a PI3K-dependent and independent pathways. Previous studies have shown that PKA modulates apoptosis either by modulating the expression of antiapoptotic or proapoptotic effectors or directly targeting the phosphorylation of apoptotic modulators or effectors at the cytoplasmic and at the mitochondrial level, leading to their sequestration or ubiquitination (53,55). It is likely that a post-transcriptional action of PKA is operating in the process of cumulus cell apoptosis because the protective effect of 8-Br-cAMP was protein synthesis-independent, being resistant to cycloheximide treatment. In agreement, the administration of 8-Br-cAMP to the COC cultures when apoptosis was ongoing completely blocked further apoptotic progression, and its removal at any time of culture induced apoptosis, indicating that the action of 8-Br-AMP was rapid and reversible.

The action of 8-Br-cAMP on matrix dissociation differs from that on apoptosis in several aspects. Conversely to apoptosis, matrix dissociation was prevented by cycloheximide, and early, but not late, administration of 8-Br-cAMP to the cultures was effective (data not shown). Thus, new proteins are required for matrix remodeling, and the elevation of cAMP probably prevents their expression. Furthermore, 8-Br-cAMP-dependent inhibition of HA release from the matrix was not counteracted by any of the kinase inhibitors tested. Moreover, the ineffectiveness of H89 was in contrast to the overall results reported above, calling into question the involvement of PKA. However, the observation that treatment with H89 alone inhibits HA release as efficiently as 8-Br-cAMP might explain this contradictory result, suggesting an involvement of the RhoA/ROCK signaling pathway in PKA regulation of this process. Actually, it has been demonstrated that the inhibitor of PKA H89 also diminishes the activity of ROCK II with similar IC50 when tested in a cell-free assay (40, 56) and that, in the cells, PKA can indirectly inhibit ROCK by phosphorylating and inactivating its stimulator RhoA (56, 57). Thus, the evidence that H89 mimics rather than inhibits cAMP (PKA)-dependent matrix-stabilizing activity suggests that ROCK inhibition is a downstream effect of PKA activity in cumulus cells. Rho/ROCK activates myosin II, thereby inducing the rearrangement of cortical actin microfilaments, which results in retraction of cytoplasmic projections and changes in cell membrane-extracellular matrix interaction. PKA has the opposite effect on the cytoskeleton, thereby promoting the formation and elongation of cytoplasmic projections in several cell types (57,59). In agreement with the advanced hypothesis, an extensive network of cellular projections is formed by cumulus cells under the gonadotropin stimulus, and disruption of actin cytoskeleton prevents the formation of the expanded matrix (60). In addition, the necessity to restrain RhoA activation to achieve full cumulus expansion has recently been proven by the evidence that inhibition of prostaglandin E2/cAMP signaling in prostaglandin E receptor EP2-deficient mice increases RhoA activation in cumulus cells and leads to alteration of cell shape and matrix organization (61). These findings, together with results reported here, suggest that cAMP-dependent inhibition of the RhoA/ROCK/myosin-actin pathway is relevant for correct assembly of the matrix and for retention of HA at the cumulus cell surface. Whatever the mechanism, the finding that apoptosis occurs in the presence of H89 although HA release is inhibited further suggests that the two processes are triggered at the same time but through distinct pathways, which are both inhibited by PKA.

However, the onset and progression of apoptosis coincide well with cumulus matrix dissociation, suggesting that deprivation of anchorage might contribute to ensure cumulus cell death. This hypothesis is also supported by the evidence that healthy cells released during cumulus disaggregation survive for days if they adhere to the plastic, thereby reverting their commitment to apoptosis (23). The observation that no significant degradation of HA occurs during cumulus dispersion (23) suggests that proteins involved in HA organization become degraded. Pericellular proteolytic degradation of adhesive proteins and consequent integrin-cytoskeleton modifications have been implicated in facilitating apoptosis in pathological conditions (62) and in physiological processes, such as involution of mammary glands after lactation and remodeling of tissues during morphogenesis (63,65). Interestingly, adhesive molecules have been detected in proximity to cumulus cell surface in ovulated COCs (50, 60, 66), and they can indirectly contribute to anchorage HA to the cell membrane by binding to the G3 domain of versican, an HA-binding proteoglycan present in the cumulus matrix (67, 68). Proteases implicated in the cleavage of adhesive proteins include tissue plasminogen activator, urokinase plamsinogen activator, matrix metalloproteinases, membrane-type metalloproteinases, and a disintegrin and metalloproteinase with thrombospondin motifs (69). Notably, mouse cumulus cells dramatically increase the expression and enzymatic activity of urokinase plamsinogen activator after completion of cumulus expansion both in vivo and in vitro, suggesting an active role of this protease in postovulatory dissolution of the cumulus (24). In addition, postovulatory oocytes release significant amounts of the proteolytic enzyme tissue plasminogen activator, which can contribute to destabilization of the cumulus matrix (24). However, these enzymes are not the sole proteases involved in the cumulus matrix degradation, and they may have a redundant role. In fact, we have found that matrix disorganization and cumulus apoptosis also occur when in vivo and in vitro expanded cumuli were cultured in the absence of oocytes or in the absence of serum, which is the source of plasminogen. ADAMTS-dependent versican proteolysis has been linked to apoptosis during limb bud development (64), and versican processing also occurs during the last phase of cumulus expansion by the increased expression of ADAMTS1 (70, 71). Certainly, versican cleavage can help loosen the HA strand network, thereby altering the interaction of HA with adhesive proteins and with cell surface receptors. Indeed, a growing body of evidence suggest that HA can also directly participate in sustaining the vitality of several cell types by binding to HA cell surface receptors, mainly to CD44 (72,75). This molecular interaction seems also to take part in the control of cumulus survival. Cumulus cells stimulated by gonadotropin to express HA also express CD44 in all examined mammalian species, including humans (50, 76,78). In addition, exogenous HA decreases the incidence of apoptosis in human cumulus cells pretreated with hyaluronidase (i.e. after removal of endogenous HA) and cultured in vitro (79), and inhibition of HA-CD44 binding with anti-CD44 antibody prevents this effect and leads to decrease of procaspase-3, -6, and -9 levels in porcine cumulus cells, suggesting that perturbation of HA-CD44 interaction leads to the activation of these caspases (80). Accordingly, the cytoplasmic tail of CD44 interacts with actin-cytoskeleton adaptor proteins (81, 82), and rearrangement of actin filaments is involved in the cell death following loss of cell anchorage by releasing apoptotic activators (i.e. Bim and Bmf), sequestered by cytoskeleton-bound proteins (83, 84). Intracellular signals generated by CD44 change in function of HA concentration (85, 86). In this regard, it should be pointed out that HA is produced at the plasma membrane by HA synthases. Therefore, HA polymers elongating by HA synthases at the cell surface can significantly contribute to the stiffness of this molecule in proximity to the cell membrane. Accordingly, we found that cumulus cell apoptosis occurs shortly after HA synthesis ceases and concomitantly with the beginning of HA release from the matrix. Thus, it is reasonable to hypothesize that decreased synthesis and increased disorganization of HA in proximity to the cells at the end of cumulus expansion play a role in the induction of cumulus cell apoptosis. Further studies are required to clarify how the intra- and extracellular pathways are integrated to cause cumulus cell apoptosis at the appropriate time after ovulation.

The cumulus oophorus is essential for in vivo oocyte fertilization. Deletion of genes involved in cumulus matrix synthesis and organization results in severe subfertility or complete sterility of female mice (7). Indeed, cumulus cells deeply influence the behavior of both oocyte and sperm in the oviduct. Glycolysis is defective in oocyte even after fertilization, and cumulus cells nurse the germ cells and the early stage embryos by providing them with pyruvate (87). In addition, soluble products as well as matrix components secreted by cumulus cells stimulate the motility, promote the capacitation, and initiate the acrosome reaction in the crossing spermatozoa, making them suitable for fertilization (15, 16). In agreement with these observations, it has long been demonstrated that a decrease of the oocyte fertilization rate occurs in parallel with a reduction of cumulus cell mass at a later time after ovulation (22). Results reported here further support the important role of cumulus cells in sustaining fertilization. We found that cAMP elevation prolongs the integrity of the cumulus, preventing cumulus cell apoptosis and matrix disassembly. More important, we demonstrated that cAMP-stabilized cumuli retain their functional properties, prolonging the fertilizability of oocytes retrieved after ovulation and cultured in vitro. Overnight culture of ovulated COCs produced a 70% reduction in normally fertilized oocytes, but when 8-Br-cAMP was added to the culture, the decrease was only 30%, giving rise to almost double the number of two-cell embryos.

In conclusion, we have demonstrated that cAMP-elevating agents prevent disaggregation of the cumulus oophorus and sustain the survival of cumulus cells, allowing them to continue to exert beneficial effects on oocyte and sperm, thereby extending in vitro the time frame of oocyte fertilizability. Cumulus cells exert a positive effect on oocyte maturation also in humans (88,91), and human cumulus cell apoptosis has been correlated with a low potential development of the enclosed oocyte (48). Therefore, these results might be of relevance in clinical practice to optimize the conditions for promoting and preserving the quality of oocytes during handling and culture of COCs retrieved from patients enrolled in programs of assisted reproduction. In addition, it will be of interest to determine whether the dual action of cAMP in the cumulus is exerted also on other HA-rich tissues, particularly at the inflammation site, where hyaluronan is expressed (92) and the protective effect of cAMP elevation through phosphodiesterase inhibitors has been proven (93,95).

Author Contributions

A. S. conceived and coordinated the study and wrote the paper. A. C. contributed drafting and revisiting it critically. M. D. G. designed and performed most of the experiments, and R. B. performed some of the experiments. F. G. K. made the figures and the movies and helped in the interpretation of the data. All authors reviewed the results and approved the final version of the manuscript.


We thank Gabriele Rossi and Graziano Bonelli for technical assistance.

*The authors declare that they have no conflicts of interest with the contents of this article.

An external file that holds a picture, illustration, etc.
Object name is sbox.jpgThis article contains supplemental Movies S1–S4.

2The abbreviations used are:

cumulus cell-oocyte complex
human chorionic gonadotropin
8-bromo-adenosine-3′,5′-cyclic monophosphate
N6,2′-O-dibutyryladenosine 3′,5′-cyclic monophosphate
8-(6-aminohexylamino)adenosine- 3′,5′-cyclic monophosphate
N6-monobutyryladenosine-3′,5′- cyclic monophosphate
8-(4-chlorophenylthio)-2′-O-methyladenosine-3′,5′-cyclic monophosphate
pregnant mares' serum gonadotropin.


1. Conti M., Hsieh M., Zamah A. M., and Oh J. S. (2012) Novel signaling mechanisms in the ovary during oocyte maturation and ovulation. Mol. Cell Endocrinol. 356, 65–73 [PMC free article] [PubMed]
2. Chian R. C., Lim J. H., and Tan S. L. (2004) State of the art in in-vitro oocyte maturation. Curr. Opin. Obstet. Gynecol. 16, 211–219 [PubMed]
3. Chang H. C., Liu H., Zhang J., Grifo J., and Krey L. C. (2005) Developmental incompetency of denuded mouse oocytes undergoing maturation in vitro is ooplasmic in nature and is associated with aberrant Oct-4 expression. Hum. Reprod. 20, 1958–1968 [PubMed]
4. Luciano A. M., Lodde V., Beretta M. S., Colleoni S., Lauria A., and Modina S. (2005) Developmental capability of denuded bovine oocyte in a co-culture system with intact cumulus-oocyte complexes: role of cumulus cells, cyclic adenosine 3′,5′-monophosphate, and glutathione. Mol. Reprod. Dev. 71, 389–397 [PubMed]
5. Chen J., Torcia S., Xie F., Lin C. J., Cakmak H., Franciosi F., Horner K., Onodera C., Song J. S., Cedars M. I., Ramalho-Santos M., and Conti M. (2013) Somatic cells regulate maternal mRNA translation and developmental competence of mouse oocytes. Nat. Cell Biol. 15, 1415–1423 [PMC free article] [PubMed]
6. Gilchrist R. B., Lane M., and Thompson J. G. (2008) Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum. Reprod. Update 14, 159–177 [PubMed]
7. Russell D. L., and Salustri A. (2006) Extracellular matrix of the cumulus-oocyte complex. Semin. Reprod. Med. 24, 217–227 [PubMed]
8. Salustri A., Yanagishita M., and Hascall V. C. (1989) Synthesis and accumulation of hyaluronic acid and proteoglycans in the mouse cumulus cell-oocyte complex during follicle-stimulating hormone-induced mucification. J. Biol. Chem. 264, 13840–13847 [PubMed]
9. Zhuo L., Yoneda M., Zhao M., Yingsung W., Yoshida N., Kitagawa Y., Kawamura K., Suzuki T., and Kimata K. (2001) Defect in SHAP-hyaluronan complex causes severe female infertility: a study by inactivation of the bikunin gene in mice. J. Biol. Chem. 276, 7693–7696 [PubMed]
10. Fülöp C., Szántó S., Mukhopadhyay D., Bárdos T., Kamath R. V., Rugg M. S., Day A. J., Salustri A., Hascall V. C., Glant T. T., and Mikecz K. (2003) Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice. Development 130, 2253–2261 [PubMed]
11. Salustri A., Garlanda C., Hirsch E., De Acetis M., Maccagno A., Bottazzi B., Doni A., Bastone A., Mantovani G., Beck Peccoz P., Salvatori G., Mahoney D. J., Day A. J., Siracusa G., Romani L., and Mantovani A. (2004) PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development 131, 1577–1586 [PubMed]
12. Scarchilli L., Camaioni A., Bottazzi B., Negri V., Doni A., Deban L., Bastone A., Salvatori G., Mantovani A., Siracusa G., and Salustri A. (2007) PTX3 interacts with inter-α-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion. J. Biol. Chem. 282, 30161–30170 [PubMed]
13. Talbot P. (1983) Videotape analysis of hamster ovulation in vitro. J. Exp. Zool. 225, 141–148 [PubMed]
14. Lam X., Gieseke C., Knoll M., and Talbot P. (2000) Assay and importance of adhesive interaction between hamster (Mesocricetus auratus) oocyte-cumulus complexes and the oviductal epithelium. Biol. Reprod. 62, 579–588 [PubMed]
15. Eisenbach M., and Giojalas L. C. (2006) Sperm guidance in mammals: an unpaved road to the egg. Nat. Rev. Mol. Cell Biol. 7, 276–285 [PubMed]
16. Jin M., Fujiwara E., Kakiuchi Y., Okabe M., Satouh Y., Baba S. A., Chiba K., and Hirohashi N. (2011) Most fertilizing mouse spermatozoa begin their acrosome reaction before contact with the zona pellucida during in vitro fertilization. Proc. Natl. Acad. Sci. U.S.A. 108, 4892–4896 [PubMed]
17. Fissore R. A., Kurokawa M., Knott J., Zhang M., and Smyth J. (2002) Mechanisms underlying oocyte activation and postovulatory ageing. Reproduction 124, 745–754 [PubMed]
18. Miao Y. L., Kikuchi K., Sun Q. Y., and Schatten H. (2009) Oocyte aging: cellular and molecular changes, developmental potential and reversal possibility. Hum. Reprod. Update 15, 573–585 [PubMed]
19. Tarín J. J., Pérez-Albalá S., and Cano A. (2000) Consequences on offspring of abnormal function in ageing gametes. Hum. Reprod. Update 6, 532–549 [PubMed]
20. Tarín J. J., Pérez-Albalá S., Pérez-Hoyos S., and Cano A. (2002) Postovulatory aging of oocytes decreases reproductive fitness and longevity of offspring. Biol. Reprod. 66, 495–499 [PubMed]
21. Wilcox A. J., Weinberg C. R., and Baird D. D. (1998) Post-ovulatory ageing of the human oocyte and embryo failure. Hum. Reprod. 13, 394–397 [PubMed]
22. Marston J. H., and Chang M. C. (1964) The fertilizable life of ova and their morphology following delayed insemination in mature and immature mice. J. Exp. Zool. 155, 237–251 [PubMed]
23. Camaioni A., Hascall V. C., Yanagishita M., and Salustri A. (1993) Effects of exogenous hyaluronic acid and serum on matrix organization and stability in the mouse cumulus cell-oocyte complex. J. Biol. Chem. 268, 20473–20481 [PubMed]
24. D'Alessandris C., Canipari R., Di Giacomo M., Epifano O., Camaioni A., Siracusa G., and Salustri A. (2001) Control of mouse cumulus cell-oocyte complex integrity before and after ovulation: plasminogen activator synthesis and matrix degradation. Endocrinology 142, 3033–3040 [PubMed]
25. Longo F. J. (1980) Aging of mouse eggs in vivo and in vitro. Gamete Res. 3, 379–393
26. Szołtys M., Tabarowski Z., and Pawlik A. (2000) Apoptosis of postovulatory cumulus granulosa cells of the rat. Anat. Embryol. 202, 523–529 [PubMed]
27. Salustri A., Yanagishita M., and Hascall V. C. (1990) Mouse oocytes regulate hyaluronic acid synthesis and mucification by FSH-stimulated cumulus cells. Dev. Biol. 138, 26–32 [PubMed]
28. Ievoli E., Lindstedt R., Inforzato A., Camaioni A., Palone F., Day A. J., Mantovani A., Salvatori G., and Salustri A. (2011) Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly. Matrix Biol. 30, 330–337 [PMC free article] [PubMed]
29. Markström E., Svensson E. C., Shao R., Svanberg B., and Billig H. (2002) Survival factors regulating ovarian apoptosis: dependence on follicle differentiation. Reproduction 123, 23–30 [PubMed]
30. Tsafriri A., Chun S. Y., Zhang R., Hsueh A. J., and Conti M. (1996) Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev. Biol. 178, 393–402 [PubMed]
31. Hussein T. S., Froiland D. A., Amato F., Thompson J. G., and Gilchrist R. B. (2005) Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. J. Cell Sci. 118, 5257–5268 [PubMed]
32. Buccione R., Vanderhyden B. C., Caron P. J., and Eppig J. J. (1990) FSH-induced expansion of the mouse cumulus oophorus in vitro is dependent upon a specific factor(s) secreted by the oocyte. Dev. Biol. 138, 16–25 [PubMed]
33. Tirone E., D'Alessandris C., Hascall V. C., Siracusa G., and Salustri A. (1997) Hyaluronan synthesis by mouse cumulus cells is regulated by interactions between follicle-stimulating hormone (or epidermal growth factor) and a soluble oocyte factor (or transforming growth factor β1). J. Biol. Chem. 272, 4787–4794 [PubMed]
34. Cheng X., Ji Z., Tsalkova T., and Mei F. (2008) Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim. Biophys. Sin. 40, 651–662 [PMC free article] [PubMed]
35. Enserink J. M., Christensen A. E., de Rooij J., van Triest M., Schwede F., Genieser H. G., Døskeland S. O., Blank J. L., and Bos J. L. (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 4, 901–906 [PubMed]
36. Christensen A. E., Selheim F., de Rooij J., Dremier S., Schwede F., Dao K. K., Martinez A., Maenhaut C., Bos J. L., Genieser H. G., and Døskeland S. O. (2003) cAMP analog mapping of Epac1 and cAMP kinase: Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278, 35394–35402 [PubMed]
37. Gonzalez-Robayna I. J., Falender A. E., Ochsner S., Firestone G. L., and Richards J. S. (2000) Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): evidence for a kinase-independent signaling by FSH in granulosa cells. Mol. Endocrinol. 14, 1283–1300 [PubMed]
38. Hunzicker-Dunn M., and Maizels E. T. (2006) FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell. Signal. 18, 1351–1359 [PMC free article] [PubMed]
39. Fan H. Y., Liu Z., Mullany L. K., and Richards J. S. (2012) Consequences of RAS and MAPK activation in the ovary: the good, the bad and the ugly. Mol. Cell Endocrinol. 356, 74–79 [PMC free article] [PubMed]
40. Lochner A., and Moolman J. A. (2006) The many faces of H89: a review. Cardiovasc. Drug Rev. 24, 261–274 [PubMed]
41. Su Y. Q., Wigglesworth K., Pendola F. L., O'Brien M. J., and Eppig J. J. (2002) Mitogen-activated protein kinase activity in cumulus cells is essential for gonadotropin-induced oocyte meiotic resumption and cumulus expansion in the mouse. Endocrinology 143, 2221–2232 [PubMed]
42. Shimada M., Hernandez-Gonzalez I., Gonzalez-Robayna I., and Richards J. S. (2006) Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: key roles for prostaglandin synthase 2 and progesterone receptor. Mol. Endocrinol. 20, 1352–1365 [PubMed]
43. Merriman J. A., Whittingham D. G., and Carroll J. (1998) The effect of follicle stimulating hormone and epidermal growth factor on the developmental capacity of in-vitro matured mouse oocytes. Hum. Reprod. 13, 690–695 [PubMed]
44. De La Fuente R., O'Brien M. J., and Eppig J. J. (1999) Epidermal growth factor enhances preimplantation developmental competence of maturing mouse oocytes. Hum. Reprod. 14, 3060–3068 [PubMed]
45. Yeo C. X., Gilchrist R. B., Thompson J. G., and Lane M. (2008) Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice. Hum. Reprod. 23, 67–73 [PubMed]
46. Gilchrist R. B. (2011) Recent insights into oocyte-follicle cell interactions provide opportunities for the development of new approaches to in vitro maturation. Reprod. Fertil. Dev. 23, 23–31 [PubMed]
47. Sutton-McDowall M. L., Mottershead D. G., Gardner D. K., Gilchrist R. B., and Thompson J. G. (2012) Metabolic differences in bovine cumulus-oocyte complexes matured in vitro in the presence or absence of follicle-stimulating hormone and bone morphogenetic protein 15. Biol. Reprod. 87, 87. [PubMed]
48. Ruvolo G., Fattouh R. R., Bosco L., Brucculeri A. M., and Cittadini E. (2013) New molecular markers for the evaluation of gamete quality. J. Assist. Reprod. Genet. 30, 207–212 [PMC free article] [PubMed]
49. Salustri A., Petrungaro S., De Felici M., Conti M., and Siracusa G. (1985) Effect of follicle-stimulating hormone on cyclic adenosine monophosphate level and on meiotic maturation in mouse cumulus cell-enclosed oocytes cultured in vitro. Biol. Reprod. 33, 797–802 [PubMed]
50. Hernandez-Gonzalez I., Gonzalez-Robayna I., Shimada M., Wayne C. M., Ochsner S. A., White L., and Richards J. S. (2006) Gene expression profiles of cumulus cell oocyte complexes during ovulation reveal cumulus cells express neuronal and immune-related genes: does this expand their role in the ovulation process? Mol. Endocrinol. 20, 1300–1321 [PubMed]
51. Downs S. M., and Hunzicker-Dunn M. (1995) Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate. Dev. Biol. 172, 72–85 [PubMed]
52. Taylor S. S., Ilouz R., Zhang P., and Kornev A. P. (2012) Assembly of allosteric macromolecular switches: lessons from PKA. Nat. Rev. Mol. Cell Biol. 13, 646–658 [PMC free article] [PubMed]
53. Matsuda-Minehata F., Inoue N., Goto Y., Manabe N. (2006) The regulation of ovarian granulosa cell death by pro- and anti-apoptotic molecules. J. Reprod. Dev. 52, 695–705 [PubMed]
54. Martin M. C., Allan L. A., Lickrish M., Sampson C., Morrice N., and Clarke P. R. (2005) Protein kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochrome c. J. Biol. Chem. 280, 15449–15455 [PubMed]
55. Naderi E. H., Findley H. W., Ruud E., Blomhoff H. K., and Naderi S. (2009) Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation. Blood 114, 608–618 [PubMed]
56. Davies S. P., Reddy H., Caivano M., and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95–105 [PubMed]
57. Dong J. M., Leung T., Manser E., and Lim L. (1998) cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKα. J. Biol. Chem. 273, 22554–22562 [PubMed]
58. Ellerbroek S. M., Wennerberg K., and Burridge K. (2003) Serine phosphorylation negatively regulates RhoA in vivo. J. Biol. Chem. 278, 19023–19031 [PubMed]
59. Leemhuis J., Boutillier S., Schmidt G., and Meyer D. K. (2002) The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho kinase. J. Pharmacol. Exp. Ther. 300, 1000–1007 [PubMed]
60. Sutovský P., Fléchon J. E., and Pavlok A. (1995) F-actin is involved in control of bovine cumulus expansion. Mol. Reprod. Dev. 41, 521–529 [PubMed]
61. Yodoi R., Tamba S., Morimoto K., Segi-Nishida E., Nishihara M., Ichikawa A., Narumiya S., and Sugimoto Y. (2009) RhoA/Rho kinase signaling in the cumulus mediates extracellular matrix assembly. Endocrinology 150, 3345–3352 [PubMed]
62. Taddei M. L., Giannoni E., Fiaschi T., and Chiarugi P. (2012) Anoikis: an emerging hallmark in health and diseases. J. Pathol. 226, 380–393 [PubMed]
63. Lund L. R., Bjørn S. F., Sternlicht M. D., Nielsen B. S., Solberg H., Usher P. A., Osterby R., Christensen I. J., Stephens R. W., Bugge T. H., Danø K., and Werb Z. (2000) Lactational competence and involution of the mouse mammary gland require plasminogen. Development 127, 4481–4492 [PubMed]
64. McCulloch D. R., Nelson C. M., Dixon L. J., Silver D. L., Wylie J. D., Lindner V., Sasaki T., Cooley M. A., Argraves W. S., and Apte S. S. (2009) ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev. Cell 17, 687–698 [PMC free article] [PubMed]
65. Ishizuya-Oka A., Hasebe T., and Shi Y. B. (2010) Apoptosis in amphibian organs during metamorphosis. Apoptosis 15, 350–364 [PMC free article] [PubMed]
66. Familiari G., Verlengia C., Nottola S. A., Renda T., Micara G., Aragona C., Zardi L., and Motta P. M. (1996) Heterogeneous distribution of fibronectin, tenascin-C, and laminin immunoreactive material in the cumulus-corona cells surrounding mature human oocytes from IVF-ET protocols: evidence that they are composed of different subpopulations: an immunohistochemical study using scanning confocal laser and fluorescence microscopy. Mol. Reprod. Dev. 43, 392–402 [PubMed]
67. Wu Y. J., La Pierre D. P., Wu J., Yee A. J., and Yang B. B. (2005) The interaction of versican with its binding partners. Cell Res. 15, 483–494 [PubMed]
68. Russell D. L., Ochsner S. A., Hsieh M., Mulders S., and Richards J. S. (2003a) Hormone-regulated expression and localization of versican in the rodent ovary. Endocrinology 144, 1020–1031 [PubMed]
69. Murphy G., and Nagase H. (2011) Localizing matrix metalloproteinase activities in the pericellular environment. FEBS J. 278, 2–15 [PMC free article] [PubMed]
70. Russell D. L., Doyle K. M., Ochsner S. A., Sandy J. D., and Richards J. S. (2003b) Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J. Biol. Chem. 278, 42330–42339 [PubMed]
71. Brown H. M., Dunning K. R., Robker R. L., Boerboom D., Pritchard M., Lane M., and Russell D. L. (2010) ADAMTS1 cleavage of versican mediates essential structural remodeling of the ovarian follicle and cumulus-oocyte matrix during ovulation in mice. Biol. Reprod. 83, 549–557 [PubMed]
72. Lisignoli G., Grassi F., Zini N., Toneguzzi S., Piacentini A., Guidolin D., Bevilacqua C., and Facchini A. (2001) Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum. 44, 1800–1807 [PubMed]
73. Onoda M., Nakaseko C., Yokota A., and Saito Y. (2009) Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line. Hematology 14, 213–219 [PubMed]
74. Bourguignon L. Y., Spevak C. C., Wong G., Xia W., and Gilad E. (2009) Hyaluronan-CD44 interaction with protein kinase Cϵ promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J. Biol. Chem. 284, 26533–26546 [PMC free article] [PubMed]
75. Vigetti D., Rizzi M., Moretto P., Deleonibus S., Dreyfuss J. M., Karousou E., Viola M., Clerici M., Hascall V. C., Ramoni M. F., De Luca G., and Passi A. (2011) Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells. J. Biol. Chem. 286, 34497–34503 [PMC free article] [PubMed]
76. Campbell S., Swann H. R., Aplin J. D., Seif M. W., Kimber S. J., and Elstein M. (1995) CD44 is expressed throughout pre-implantation human embryo development. Hum. Reprod. 10, 425–430 [PubMed]
77. Yokoo M., Miyahayashi Y., Naganuma T., Kimura N., Sasada H., and Sato E. (2002) Identification of hyaluronic acid-binding proteins and their expressions in porcine cumulus-oocyte complexes during in vitro maturation. Biol. Reprod. 67, 1165–1171 [PubMed]
78. Assidi M., Dufort I., Ali A., Hamel M., Algriany O., Dielemann S., and Sirard M. A. (2008) Identification of potential markers of oocyte competence expressed in bovine cumulus cells matured with follicle-stimulating hormone and/or phorbol myristate acetate in vitro. Biol. Reprod. 79, 209–222 [PubMed]
79. Kaneko T., Saito H., Toya M., Satio T., Nakahara K., and Hiroi M. (2000) Hyaluronic acid inhibits apoptosis in granulosa cells via CD44. J. Assist. Reprod. Genet. 17, 162–167 [PMC free article] [PubMed]
80. Tunjung W. A., Yokoo M., Hoshino Y., Miyake Y., Kadowaki A., and Sato E. (2009) Effect of hyaluronan to inhibit caspase activation in porcine granulosa cells. Biochem. Biophys. Res. Commun. 382, 160–164 [PubMed]
81. Lokeshwar V. B., Fregien N., and Bourguignon L. Y. (1994) Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126, 1099–1109 [PMC free article] [PubMed]
82. Tsukita S., Oishi K., Sato N., Sagara J., Kawai A., and Tsukita S. (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126, 391–401 [PMC free article] [PubMed]
83. Puthalakath H., Huang D. C., O'Reilly L. A., King S. M., and Strasser A. (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3, 287–296 [PubMed]
84. Puthalakath H., Villunger A., O'Reilly L. A., Beaumont J. G., Coultas L., Cheney R. E., Huang D. C., and Strasser A. (2001) Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 293, 1829–1832 [PubMed]
85. Toole B. P. (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528–539 [PubMed]
86. Keller K. E., Sun Y. Y., Vranka J. A., Hayashi L., and Acott T. S. (2012) Inhibition of hyaluronan synthesis reduces versican and fibronectin levels in trabecular meshwork cells. PLoS One 7, e48523. [PMC free article] [PubMed]
87. Biggers J. D., Whittingham D. G., and Donahue R. P. (1967) The pattern of energy metabolism in the mouse oocyte and zygote. Proc. Natl. Acad. Sci. U.S.A. 58, 560–567 [PubMed]
88. Zhang A., Xu B., Sun Y., Lu X., Niu Z., Chen Q., Feng Y., and Xu C. (2012) The effect of human cumulus cells on the maturation and developmental potential of immature oocytes in ICSI cycles. J. Assist. Reprod. Genet. 29, 313–319 [PMC free article] [PubMed]
89. Assou S., Haouzi D., Mahmoud K., Aouacheria A., Guillemin Y., Pantesco V., Rème T., Dechaud H., De Vos J., and Hamamah S. (2008) A non-invasive test for assessing embryo potential by gene expression profiles of human cumulus cells: a proof of concept study. Mol. Hum. Reprod. 14, 711–719 [PubMed]
90. Ouandaogo Z. G., Frydman N., Hesters L., Assou S., Haouzi D., Dechaud H., Frydman R., and Hamamah S. (2012) Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo and in vitro oocyte maturation. Hum. Reprod. 27, 2438–2447 [PubMed]
91. Coticchio G., Dal-Canto M., Guglielmo M. C., Mignini-Renzini M., and Fadini R. (2012) Human oocyte maturation in vitro. Int. J. Dev. Biol. 56, 909–918 [PubMed]
92. Petrey A. C., and de la Motte C. A. (2014) Hyaluronan, a crucial regulator of inflammation. Front. Immunol. 5, 101. [PMC free article] [PubMed]
93. Page C. P., and Spina D. (2011) Phosphodiesterase inhibitors in the treatment of inflammatory diseases. Handb. Exp. Pharmacol. 204, 391–414 [PubMed]
94. López-Campos J. L., Calero Acuña C. (2013) What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease? Expert Rev. Respir. Med. 7, 43–51 [PubMed]
95. Titus D. J., Oliva A. A., Wilson N. M., Atkins C. M. (2015) Phosphodiesterase inhibitors as therapeutics for traumatic brain injury. Curr. Pharm. Des. 21, 332–342 [PMC free article] [PubMed]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology